The Philadelphia chromosome in CML gives rise to constitutively active protein tyrosine kinase product BCR-ABL, which is important because in patients with CML, there is clonal expansion of hematopoietic cells that express this fusion gene. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.